Biotech pharma

ResistanceBio

Website
Founded 2016Origin source ↗Checked 2026-09-15

Overview

We solve drug resistance for cancer

Company description As recorded 2026-11-08
Biotech pharmaBusinessesEnterpriseLicensing

Founders & team

Previously Viosera Therapeutics

Company history As recorded 2026-11-08

Nicholas Goldner

Founder/CEO

I have a PhD in molecular cell biology, I figure out how living cells thrive in hostile environments. I'm fascinated by how living organisms, people, organizations, etc. adapt and evolve when faced with hostility. I use these skills to understand which companies, ideas, or projects are most likely to succeed. I'm a technical founder and I enjoy building companies.

LinkedIn
Founder profile As recorded 2026-09-15

Christopher Bulow

Founder

Founded Viosera Therapeutics to develop resistance-proof antimicrobial drugs and founded resistanceBio to help pharma avoid drug resistance in cancer

LinkedIn
Founder profile As recorded 2026-09-15
15team members reported
Source-reported As recorded 2026-09-15

Founded 2016 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA; Overland, MO, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The source reports an inactive or acquired company; current product identity needs review.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year
startup.observe Directory coverage · Sources & method